IMPURITIES AVAILABLE FOR 'Bitopertin'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Bitopertin. Bitopertin is an investigational glycine reuptake inhibitor that targets the glycine transporter type 1 (GlyT1) in the central nervous system. By inhibiting glycine reuptake, it increases glycine concentrations at NMDA receptors, enhancing glutamatergic neurotransmission. Bitopertin was initially developed for the treatment of schizophrenia, aiming to improve negative and cognitive symptoms by modulating NMDA receptor function. Although early studies showed promise, later-stage clinical trials yielded mixed results, leading to a halt in some schizophrenia-related developments. More recently, it has gained interest as a potential therapy for erythropoietic protoporphyria (EPP) by modulating heme biosynthesis. Bitopertin is generally well tolerated in clinical studies, with side effects including fatigue, headache, and gastrointestinal disturbances. Research on its broader neurological and metabolic applications continues. Buy high quality Bitopertin from Omsynth Lifesciences.